Zoetis Inc. (NYSE:ZTS) Shares Purchased by KPP Advisory Services LLC

KPP Advisory Services LLC raised its position in Zoetis Inc. (NYSE:ZTS) by 7.4% during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 5,000 shares of the company’s stock after purchasing an additional 345 shares during the quarter. KPP Advisory Services LLC’s holdings in Zoetis were worth $867,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds also recently made changes to their positions in the business. Aveo Capital Partners LLC acquired a new position in shares of Zoetis during the fourth quarter valued at $225,000. Evoke Wealth LLC increased its stake in Zoetis by 14.1% during the 4th quarter. Evoke Wealth LLC now owns 1,675 shares of the company’s stock valued at $331,000 after buying an additional 207 shares during the period. Jones Financial Companies Lllp raised its position in shares of Zoetis by 8.7% during the 4th quarter. Jones Financial Companies Lllp now owns 25,213 shares of the company’s stock worth $4,976,000 after buying an additional 2,024 shares in the last quarter. The Manufacturers Life Insurance Company lifted its stake in shares of Zoetis by 20.2% in the 4th quarter. The Manufacturers Life Insurance Company now owns 588,799 shares of the company’s stock worth $116,211,000 after acquiring an additional 98,878 shares during the period. Finally, NEOS Investment Management LLC boosted its holdings in shares of Zoetis by 45.7% in the fourth quarter. NEOS Investment Management LLC now owns 6,537 shares of the company’s stock valued at $1,290,000 after acquiring an additional 2,049 shares in the last quarter. Institutional investors own 92.80% of the company’s stock.

Zoetis Stock Up 0.3 %

Shares of Zoetis stock opened at $195.38 on Tuesday. The company has a quick ratio of 2.09, a current ratio of 3.45 and a debt-to-equity ratio of 1.32. Zoetis Inc. has a 12-month low of $144.80 and a 12-month high of $201.92. The firm has a market capitalization of $88.52 billion, a PE ratio of 37.65, a price-to-earnings-growth ratio of 2.99 and a beta of 0.88. The stock’s fifty day moving average is $186.33 and its 200-day moving average is $174.93.

Zoetis (NYSE:ZTS) last posted its quarterly earnings data on Tuesday, August 6th. The company reported $1.56 EPS for the quarter, beating analysts’ consensus estimates of $1.49 by $0.07. Zoetis had a net margin of 26.29% and a return on equity of 50.67%. The company had revenue of $2.36 billion during the quarter, compared to analyst estimates of $2.31 billion. During the same period in the prior year, the firm earned $1.41 earnings per share. The business’s quarterly revenue was up 8.3% on a year-over-year basis. Equities analysts anticipate that Zoetis Inc. will post 5.84 earnings per share for the current year.

Analyst Upgrades and Downgrades

Several brokerages recently commented on ZTS. Stifel Nicolaus boosted their target price on Zoetis from $200.00 to $210.00 and gave the stock a “buy” rating in a report on Wednesday, September 18th. Piper Sandler boosted their price objective on Zoetis from $195.00 to $210.00 and gave the stock an “overweight” rating in a research note on Wednesday, August 14th. Argus raised Zoetis to a “strong-buy” rating in a research note on Friday, August 9th. Finally, BTIG Research boosted their price target on shares of Zoetis from $220.00 to $225.00 and gave the stock a “buy” rating in a research report on Monday, August 12th. Nine analysts have rated the stock with a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat, Zoetis currently has a consensus rating of “Buy” and a consensus target price of $220.38.

Zoetis Company Profile

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.